| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/14/2001 | WO2001042216A2 Caspase inhibitors and uses thereof |
| 06/14/2001 | WO2001042215A1 4-pyridinyl-n-acyl-l-phenylalanines |
| 06/14/2001 | WO2001042205A2 Treatment of inflammatory bowel disease with vitamin d compounds |
| 06/14/2001 | WO2001042194A1 Adamantane derivatives |
| 06/14/2001 | WO2001042191A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/14/2001 | WO2001042189A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 06/14/2001 | WO2001041794A2 Activated amylase |
| 06/14/2001 | WO2001041782A2 Method for administering a cytokine to the central nervous system and the lymphatic system |
| 06/14/2001 | WO2001041768A2 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 06/14/2001 | WO2001041762A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041761A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | WO2001041753A2 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 06/14/2001 | WO2001041733A2 Compressed tablet composition comprising a nsaid |
| 06/14/2001 | WO2001041696A1 Electro-static stimulation of human body |
| 06/14/2001 | WO2001041573A1 Therapeutic antimicrobial compositions |
| 06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001027111A3 Bicyclic imidazo-3-yl-amine derivatives |
| 06/14/2001 | WO2001003720A3 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 06/14/2001 | WO2001000812A3 22012, a novel human carboxypeptidase |
| 06/14/2001 | WO2000032631A3 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof |
| 06/14/2001 | US20010003752 Crystalline form of 4- [ 5-methyl-3-phenylisoxazol-4-yl ] benzenesulfonamide |
| 06/14/2001 | US20010003750 Used as research tools in pharmacological, diagnostic studies and treatment of diseases in mammals in which 1L-beta-protease activity is implicated; antiinflammatory agent |
| 06/14/2001 | US20010003589 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/14/2001 | CA2733434A1 Caspase inhibitors and uses thereof |
| 06/14/2001 | CA2394917A1 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | CA2394891A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | CA2394236A1 Adamantane derivatives |
| 06/14/2001 | CA2393688A1 Method for administering a cytokine to the central nervous system and the lymphatic system |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392740A1 Il-6 like polynucleotides, polypeptides, and antibodies |
| 06/14/2001 | CA2392584A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | CA2392566A1 4-pyridinyl-n-acyl-l-phenylalanines |
| 06/14/2001 | CA2390859A1 Treatment of inflammatory bowel disease with vitamin d compounds |
| 06/14/2001 | CA2390093A1 Extracellular matrix and cell adhesion molecules |
| 06/14/2001 | CA2384982A1 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | CA2362606A1 Therapeutic antimicrobial compositions |
| 06/14/2001 | CA2361647A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/13/2001 | EP1106615A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106614A1 5-Membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106180A1 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 06/13/2001 | EP1106175A1 Anti-inflammatory analgesics |
| 06/13/2001 | EP1105728A1 Modulating multiple lineage kinase proteins |
| 06/13/2001 | EP1105518A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 06/13/2001 | EP1105504A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
| 06/13/2001 | EP1105501A2 Tpl-2/cot kinase and methods of use |
| 06/13/2001 | EP1105485A1 Human il-1 epsilon dna and polypeptides |
| 06/13/2001 | EP1105478A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 06/13/2001 | EP1105467A1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 06/13/2001 | EP1105421A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 06/13/2001 | EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 06/13/2001 | EP1105395A1 Photocyclized rapamycins |
| 06/13/2001 | EP1105390A2 New compounds |
| 06/13/2001 | EP1105389A1 Integrin receptor antagonists |
| 06/13/2001 | EP1105384A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 06/13/2001 | EP1105382A2 Method for the preparation of citalopram |
| 06/13/2001 | EP1105378A1 Quinazoline derivatives |
| 06/13/2001 | EP1105371A2 Novel aryl sulphonamide amino acid esters and analogues |
| 06/13/2001 | EP1105370A1 Novel aryl sulphonamides and analogues |
| 06/13/2001 | EP1105143A1 Human histone deacetylase gene hd4 |
| 06/13/2001 | EP1105142A2 Blood-brain barrier therapeutics |
| 06/13/2001 | EP1105139A1 Ophthalmic solution with tetracycline for topical treatment of dry eye disease |
| 06/13/2001 | EP1105121A1 Ascorbate-isoquercetin compositions |
| 06/13/2001 | EP1105114A1 Nimesulide containiing topical pharmaceutical compositions |
| 06/13/2001 | EP1105109A1 Injectable formulations of nanoparticulate naproxen |
| 06/13/2001 | EP0863870B1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 06/13/2001 | EP0727990B1 Compounds, compositions and treatment of allergies and inflammation |
| 06/13/2001 | CN1299347A Inhibitor of phospholipase enzymes |
| 06/13/2001 | CN1299278A Inhibition of angiogenesis |
| 06/13/2001 | CN1298740A Medicinal composition for treating bone fracture, injury and rheumatism |
| 06/13/2001 | CN1298717A Process for preparing Tibetan medicines |
| 06/13/2001 | CN1298710A Process for preparing exterior-applied plaster |
| 06/13/2001 | CN1067075C Pyrrolo-gyrrolone used as neutrophil elastase inhibitor |
| 06/13/2001 | CN1067067C 杂环速激肽受体拮抗物 Heterocyclic tachykinin receptor antagonists |
| 06/13/2001 | CN1067054C 1H-indole-3-glyoxylamide 5 PLA 2 inhibitors |
| 06/12/2001 | US6245883 An isolated lectin derived peptide; therapy, antiinflammatory agent, suppressing cell adhesion, antimetastasis agents |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245802 Method for treating pain |
| 06/12/2001 | US6245801 Branched alkyl pyrrolidine-3-carboxylic acids |
| 06/12/2001 | US6245790 Oxazole compounds useful as PGE2 agonists and antagonists |
| 06/12/2001 | US6245779 Naphthyridine derivatives |
| 06/12/2001 | US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer |
| 06/12/2001 | US6245760 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/12/2001 | US6245759 Tyrosine kinase inhibitors |
| 06/12/2001 | US6245738 Cytokine restraining agents |
| 06/12/2001 | US6245544 An isolated polypeptide having a specific amino acid sequence; antiproliferative, anticarcinogenic, antitumor, antiarthritic, antiinflammatory agents; metastatsis; psoriasis; vision defects |
| 06/12/2001 | US6245357 Extended release dosage form |
| 06/12/2001 | US6245355 Sustained release matrix for high-dose insoluble drugs |
| 06/12/2001 | US6245342 Mixture of oligopeptide, enzyme and carrier |
| 06/12/2001 | US6245332 Modulation of systemic memory T cell trafficking |
| 06/12/2001 | CA2125665C Medicaments |
| 06/12/2001 | CA2080917C New pharmacologically active catechol derivatives |
| 06/11/2001 | WO2001044230A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/11/2001 | CA2393310A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |